Phase 1/2a safety, tolerability, PK and PD study of AKCEA-APOCIII-LRx in healthy volunteers with elevated triglycerides (NCT0290027)

Educational partners and supporters (others pending)

Amarin Logo
Ionis Logo
Kowa Logo
Pfizer Logo